| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Extremely Premature | 22 | 2024 | 81 | 3.420 |
Why?
|
| Swine | 93 | 2024 | 1155 | 3.110 |
Why?
|
| Enterocolitis, Necrotizing | 27 | 2024 | 237 | 3.000 |
Why?
|
| Intestinal Mucosa | 43 | 2020 | 765 | 2.830 |
Why?
|
| Animals, Newborn | 59 | 2024 | 988 | 2.690 |
Why?
|
| Enteral Nutrition | 30 | 2023 | 250 | 2.510 |
Why?
|
| Infant, Premature, Diseases | 13 | 2023 | 238 | 1.940 |
Why?
|
| Infant, Premature | 31 | 2024 | 798 | 1.940 |
Why?
|
| Neonatal Sepsis | 7 | 2024 | 29 | 1.700 |
Why?
|
| Protein Biosynthesis | 21 | 2022 | 666 | 1.560 |
Why?
|
| Parenteral Nutrition | 17 | 2022 | 183 | 1.480 |
Why?
|
| Infant, Newborn | 78 | 2024 | 8070 | 1.460 |
Why?
|
| Citrulline | 9 | 2024 | 84 | 1.450 |
Why?
|
| Glucagon-Like Peptide 2 | 20 | 2019 | 54 | 1.280 |
Why?
|
| Parenteral Nutrition, Total | 19 | 2014 | 114 | 1.230 |
Why?
|
| Stillbirth | 9 | 2022 | 79 | 1.210 |
Why?
|
| Intestine, Small | 12 | 2019 | 302 | 1.200 |
Why?
|
| Leadership | 2 | 2021 | 227 | 1.190 |
Why?
|
| Intestines | 25 | 2021 | 571 | 1.180 |
Why?
|
| Amino Acids | 19 | 2023 | 651 | 1.170 |
Why?
|
| Glutamic Acid | 12 | 2013 | 194 | 1.050 |
Why?
|
| Short Bowel Syndrome | 7 | 2020 | 59 | 1.040 |
Why?
|
| Premature Birth | 16 | 2022 | 380 | 1.040 |
Why?
|
| Liver | 23 | 2023 | 1727 | 0.930 |
Why?
|
| Intestinal Absorption | 18 | 2017 | 190 | 0.920 |
Why?
|
| Animals | 122 | 2024 | 33693 | 0.880 |
Why?
|
| Gestational Age | 23 | 2022 | 1116 | 0.830 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2020 | 317 | 0.820 |
Why?
|
| Arginine | 8 | 2024 | 298 | 0.820 |
Why?
|
| Adaptation, Physiological | 9 | 2019 | 262 | 0.810 |
Why?
|
| Streptococcal Infections | 2 | 2022 | 244 | 0.810 |
Why?
|
| Intestinal Perforation | 5 | 2024 | 59 | 0.780 |
Why?
|
| Birth Weight | 7 | 2024 | 336 | 0.750 |
Why?
|
| Animal Nutritional Physiological Phenomena | 8 | 2021 | 61 | 0.750 |
Why?
|
| Fat Emulsions, Intravenous | 6 | 2021 | 71 | 0.710 |
Why?
|
| Licensure, Medical | 1 | 2020 | 24 | 0.680 |
Why?
|
| Medicine | 1 | 2021 | 97 | 0.680 |
Why?
|
| Gastrointestinal Tract | 7 | 2018 | 208 | 0.660 |
Why?
|
| Peptides | 10 | 2014 | 798 | 0.660 |
Why?
|
| Escherichia coli Infections | 2 | 2020 | 191 | 0.650 |
Why?
|
| Glutamine | 14 | 2018 | 195 | 0.650 |
Why?
|
| Female | 102 | 2024 | 65309 | 0.640 |
Why?
|
| Physicians, Women | 1 | 2019 | 46 | 0.630 |
Why?
|
| Bile Acids and Salts | 6 | 2022 | 233 | 0.620 |
Why?
|
| Neurodevelopmental Disorders | 7 | 2021 | 469 | 0.620 |
Why?
|
| Pediatricians | 1 | 2019 | 65 | 0.620 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2023 | 171 | 0.620 |
Why?
|
| United States | 27 | 2023 | 10595 | 0.600 |
Why?
|
| Fluid Therapy | 2 | 2018 | 122 | 0.600 |
Why?
|
| Jejunum | 7 | 2020 | 128 | 0.590 |
Why?
|
| Pregnancy | 37 | 2022 | 7115 | 0.570 |
Why?
|
| Infant Nutritional Physiological Phenomena | 6 | 2020 | 191 | 0.560 |
Why?
|
| Receptors, Glucagon | 3 | 2014 | 29 | 0.540 |
Why?
|
| Models, Animal | 7 | 2021 | 465 | 0.540 |
Why?
|
| Diarrhea | 1 | 2018 | 315 | 0.540 |
Why?
|
| Ileum | 6 | 2020 | 132 | 0.530 |
Why?
|
| Humans | 109 | 2024 | 122997 | 0.530 |
Why?
|
| Amino Acids, Sulfur | 4 | 2009 | 15 | 0.510 |
Why?
|
| Disease Models, Animal | 15 | 2024 | 4263 | 0.510 |
Why?
|
| Soybean Oil | 8 | 2021 | 65 | 0.510 |
Why?
|
| Intracranial Hemorrhages | 5 | 2022 | 73 | 0.490 |
Why?
|
| Sus scrofa | 10 | 2020 | 122 | 0.490 |
Why?
|
| Fish Oils | 7 | 2021 | 82 | 0.480 |
Why?
|
| Escherichia coli | 1 | 2020 | 980 | 0.480 |
Why?
|
| Fatty Liver | 3 | 2012 | 176 | 0.470 |
Why?
|
| Bronchopulmonary Dysplasia | 6 | 2022 | 184 | 0.470 |
Why?
|
| Infant | 24 | 2024 | 12286 | 0.460 |
Why?
|
| Digestive System | 3 | 2003 | 59 | 0.460 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 60 | 0.450 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2019 | 443 | 0.440 |
Why?
|
| Cholestasis | 4 | 2021 | 148 | 0.440 |
Why?
|
| Dietary Proteins | 9 | 2011 | 242 | 0.440 |
Why?
|
| Syphilis, Congenital | 4 | 2019 | 28 | 0.440 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1253 | 0.430 |
Why?
|
| Muscle, Skeletal | 6 | 2023 | 939 | 0.420 |
Why?
|
| Leukomalacia, Periventricular | 4 | 2018 | 13 | 0.420 |
Why?
|
| Child Welfare | 1 | 2013 | 66 | 0.420 |
Why?
|
| Ornithine | 1 | 2012 | 25 | 0.420 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 24 | 0.410 |
Why?
|
| Milk, Human | 4 | 2024 | 296 | 0.410 |
Why?
|
| Liver Diseases | 5 | 2020 | 362 | 0.410 |
Why?
|
| Prospective Studies | 18 | 2024 | 6023 | 0.400 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2018 | 226 | 0.400 |
Why?
|
| Diet | 9 | 2018 | 1125 | 0.400 |
Why?
|
| Animal Feed | 6 | 2018 | 76 | 0.400 |
Why?
|
| Leucine | 9 | 2023 | 309 | 0.400 |
Why?
|
| Male | 66 | 2024 | 59901 | 0.400 |
Why?
|
| Cesarean Section | 8 | 2021 | 381 | 0.390 |
Why?
|
| Organ Size | 10 | 2016 | 412 | 0.390 |
Why?
|
| Amino Acids, Essential | 3 | 2018 | 26 | 0.390 |
Why?
|
| Polyethylene Glycols | 2 | 2024 | 216 | 0.380 |
Why?
|
| Fatty Acids | 4 | 2021 | 340 | 0.380 |
Why?
|
| Research | 1 | 2013 | 263 | 0.380 |
Why?
|
| Phytosterols | 3 | 2021 | 27 | 0.360 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 130 | 0.360 |
Why?
|
| Infant Mortality | 8 | 2023 | 175 | 0.360 |
Why?
|
| Sepsis | 4 | 2020 | 478 | 0.350 |
Why?
|
| Insulin | 7 | 2024 | 1197 | 0.350 |
Why?
|
| Hepatitis | 1 | 2010 | 59 | 0.350 |
Why?
|
| Portal Vein | 6 | 2007 | 91 | 0.340 |
Why?
|
| Glucose | 12 | 2024 | 869 | 0.340 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 4 | 2019 | 79 | 0.340 |
Why?
|
| Phenylalanine | 3 | 1999 | 120 | 0.340 |
Why?
|
| Streptococcus agalactiae | 2 | 2022 | 105 | 0.340 |
Why?
|
| Isotope Labeling | 3 | 2017 | 102 | 0.330 |
Why?
|
| Ketoglutaric Acids | 5 | 2006 | 24 | 0.320 |
Why?
|
| Insulin Resistance | 2 | 2012 | 638 | 0.320 |
Why?
|
| Gastric Mucosa | 3 | 2009 | 483 | 0.320 |
Why?
|
| Lactase | 5 | 2009 | 41 | 0.320 |
Why?
|
| Methionine | 5 | 2011 | 102 | 0.320 |
Why?
|
| Phospholipids | 3 | 2019 | 107 | 0.320 |
Why?
|
| Life Support Care | 2 | 2020 | 45 | 0.320 |
Why?
|
| Withholding Treatment | 2 | 2020 | 67 | 0.320 |
Why?
|
| Pregnancy in Diabetics | 2 | 2020 | 24 | 0.320 |
Why?
|
| Glucagon-Like Peptides | 12 | 2011 | 34 | 0.320 |
Why?
|
| Vitamin E | 3 | 2019 | 64 | 0.310 |
Why?
|
| Incidence | 6 | 2023 | 3047 | 0.310 |
Why?
|
| Developmental Disabilities | 4 | 2021 | 695 | 0.310 |
Why?
|
| Fetal Development | 3 | 2018 | 111 | 0.310 |
Why?
|
| Oxidation-Reduction | 11 | 2012 | 445 | 0.300 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 304 | 0.290 |
Why?
|
| Nutritional Physiological Phenomena | 6 | 2019 | 92 | 0.290 |
Why?
|
| Docosahexaenoic Acids | 2 | 2019 | 66 | 0.290 |
Why?
|
| Postprandial Period | 2 | 2004 | 77 | 0.290 |
Why?
|
| Infant, Extremely Low Birth Weight | 6 | 2021 | 38 | 0.290 |
Why?
|
| Fibroblast Growth Factors | 4 | 2022 | 154 | 0.280 |
Why?
|
| Lysine | 3 | 2003 | 200 | 0.280 |
Why?
|
| Laparotomy | 3 | 2024 | 135 | 0.280 |
Why?
|
| Colostrum | 3 | 2017 | 54 | 0.280 |
Why?
|
| Inflammation | 6 | 2024 | 1400 | 0.280 |
Why?
|
| Splanchnic Circulation | 4 | 2011 | 52 | 0.280 |
Why?
|
| Indomethacin | 3 | 2017 | 84 | 0.280 |
Why?
|
| Gastrointestinal Diseases | 2 | 2009 | 335 | 0.280 |
Why?
|
| Swine Diseases | 3 | 2020 | 36 | 0.270 |
Why?
|
| Growth | 3 | 2014 | 105 | 0.270 |
Why?
|
| Cohort Studies | 10 | 2022 | 4705 | 0.260 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2018 | 51 | 0.260 |
Why?
|
| Blood Glucose | 3 | 2019 | 1113 | 0.260 |
Why?
|
| Patient Discharge | 3 | 2019 | 488 | 0.260 |
Why?
|
| Placenta | 3 | 2022 | 493 | 0.260 |
Why?
|
| Nitrogen | 2 | 2012 | 132 | 0.260 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2014 | 168 | 0.260 |
Why?
|
| Adult | 23 | 2022 | 28980 | 0.250 |
Why?
|
| Dietary Supplements | 5 | 2018 | 471 | 0.250 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 353 | 0.250 |
Why?
|
| Lipopolysaccharides | 3 | 2024 | 291 | 0.250 |
Why?
|
| Live Birth | 3 | 2022 | 54 | 0.240 |
Why?
|
| Hydrolases | 2 | 2024 | 52 | 0.240 |
Why?
|
| Hospital Mortality | 5 | 2022 | 1002 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 2395 | 0.240 |
Why?
|
| Pregnancy Complications | 2 | 2020 | 505 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2016 | 1684 | 0.230 |
Why?
|
| Hydrocortisone | 2 | 2022 | 214 | 0.230 |
Why?
|
| Young Adult | 9 | 2022 | 8840 | 0.230 |
Why?
|
| Lactose | 3 | 2018 | 54 | 0.230 |
Why?
|
| Syphilis | 3 | 2019 | 95 | 0.230 |
Why?
|
| Endotoxemia | 1 | 2024 | 56 | 0.220 |
Why?
|
| Homeostasis | 2 | 2021 | 681 | 0.220 |
Why?
|
| Food, Formulated | 4 | 2012 | 52 | 0.220 |
Why?
|
| Drainage | 2 | 2024 | 254 | 0.220 |
Why?
|
| Signal Transduction | 9 | 2021 | 4507 | 0.220 |
Why?
|
| Threonine | 4 | 2012 | 60 | 0.220 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 678 | 0.220 |
Why?
|
| beta Carotene | 1 | 2023 | 41 | 0.220 |
Why?
|
| Infant Formula | 4 | 2024 | 98 | 0.210 |
Why?
|
| Body Weight | 6 | 2018 | 999 | 0.210 |
Why?
|
| Emulsions | 5 | 2021 | 65 | 0.210 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2018 | 92 | 0.210 |
Why?
|
| Carbon Isotopes | 7 | 2017 | 271 | 0.210 |
Why?
|
| Cerebral Hemorrhage | 3 | 2020 | 142 | 0.200 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2015 | 133 | 0.200 |
Why?
|
| Placental Insufficiency | 1 | 2022 | 13 | 0.200 |
Why?
|
| Biological Availability | 5 | 2021 | 128 | 0.200 |
Why?
|
| Prenatal Care | 6 | 2020 | 340 | 0.200 |
Why?
|
| Bacteria | 2 | 2022 | 483 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2021 | 384 | 0.200 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 160 | 0.200 |
Why?
|
| Parturition | 1 | 2022 | 62 | 0.200 |
Why?
|
| Probiotics | 2 | 2023 | 207 | 0.200 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 407 | 0.190 |
Why?
|
| Homocysteine | 4 | 2011 | 121 | 0.190 |
Why?
|
| Digestive System Physiological Phenomena | 2 | 2000 | 10 | 0.190 |
Why?
|
| Risk Factors | 13 | 2021 | 9974 | 0.190 |
Why?
|
| Kinetics | 10 | 2021 | 1313 | 0.190 |
Why?
|
| Retrospective Studies | 17 | 2022 | 15930 | 0.190 |
Why?
|
| Fungemia | 1 | 2021 | 22 | 0.190 |
Why?
|
| Triglycerides | 4 | 2019 | 561 | 0.190 |
Why?
|
| Anti-Infective Agents | 2 | 2022 | 266 | 0.190 |
Why?
|
| Cysteine | 4 | 2011 | 133 | 0.190 |
Why?
|
| Viscera | 3 | 2006 | 55 | 0.190 |
Why?
|
| Duodenum | 2 | 2020 | 99 | 0.190 |
Why?
|
| Nitric Oxide | 3 | 2018 | 432 | 0.190 |
Why?
|
| Oxylipins | 1 | 2021 | 4 | 0.190 |
Why?
|
| Proteins | 7 | 2006 | 1038 | 0.190 |
Why?
|
| Random Allocation | 6 | 2018 | 423 | 0.190 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 20 | 0.180 |
Why?
|
| Gastric Emptying | 2 | 2013 | 78 | 0.180 |
Why?
|
| Muscle Proteins | 3 | 2022 | 417 | 0.180 |
Why?
|
| Child Development | 1 | 2023 | 252 | 0.180 |
Why?
|
| Meningitis | 1 | 2021 | 99 | 0.180 |
Why?
|
| Sodium Glutamate | 2 | 2013 | 6 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 327 | 0.180 |
Why?
|
| Eating | 3 | 2019 | 373 | 0.180 |
Why?
|
| Antimicrobial Stewardship | 1 | 2022 | 84 | 0.180 |
Why?
|
| Biomarkers | 4 | 2024 | 2940 | 0.180 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2023 | 162 | 0.180 |
Why?
|
| Alanine | 4 | 2023 | 181 | 0.170 |
Why?
|
| Cerebral Ventricles | 1 | 2020 | 80 | 0.170 |
Why?
|
| Kidney | 5 | 2019 | 1337 | 0.170 |
Why?
|
| Colitis | 2 | 2012 | 152 | 0.170 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2020 | 71 | 0.170 |
Why?
|
| Retinopathy of Prematurity | 2 | 2022 | 56 | 0.170 |
Why?
|
| Work-Life Balance | 1 | 2019 | 3 | 0.170 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 182 | 0.170 |
Why?
|
| Child, Preschool | 5 | 2022 | 13819 | 0.160 |
Why?
|
| Cytokines | 3 | 2024 | 1280 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 281 | 0.160 |
Why?
|
| Gender Identity | 1 | 2019 | 69 | 0.160 |
Why?
|
| Infant Equipment | 1 | 2018 | 5 | 0.160 |
Why?
|
| Incubators, Infant | 1 | 2018 | 4 | 0.160 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 109 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 795 | 0.160 |
Why?
|
| Neonatal Screening | 2 | 2018 | 184 | 0.160 |
Why?
|
| Rifampin | 1 | 2019 | 145 | 0.160 |
Why?
|
| Resuscitation | 2 | 2018 | 244 | 0.160 |
Why?
|
| Morbidity | 4 | 2022 | 240 | 0.160 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2018 | 19 | 0.160 |
Why?
|
| High Fructose Corn Syrup | 1 | 2018 | 7 | 0.160 |
Why?
|
| Clostridium | 1 | 2018 | 16 | 0.160 |
Why?
|
| Gammaproteobacteria | 1 | 2018 | 16 | 0.150 |
Why?
|
| Carbon Dioxide | 9 | 2013 | 273 | 0.150 |
Why?
|
| Bacillus | 1 | 2018 | 34 | 0.150 |
Why?
|
| Metabolome | 1 | 2020 | 294 | 0.150 |
Why?
|
| Logistic Models | 6 | 2022 | 1796 | 0.150 |
Why?
|
| Carrier State | 1 | 1998 | 76 | 0.150 |
Why?
|
| Kupffer Cells | 1 | 2017 | 19 | 0.150 |
Why?
|
| Endotoxins | 1 | 2017 | 47 | 0.150 |
Why?
|
| Hepatocytes | 2 | 2017 | 225 | 0.150 |
Why?
|
| Portal System | 9 | 2007 | 32 | 0.150 |
Why?
|
| Milk Proteins | 1 | 1998 | 91 | 0.150 |
Why?
|
| Epithelial Cells | 4 | 2013 | 900 | 0.150 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 117 | 0.140 |
Why?
|
| Jejunostomy | 2 | 2014 | 20 | 0.140 |
Why?
|
| Brain | 4 | 2019 | 2943 | 0.140 |
Why?
|
| Bacteremia | 1 | 2021 | 406 | 0.140 |
Why?
|
| Pregnant Women | 1 | 2018 | 149 | 0.140 |
Why?
|
| Nutritional Support | 2 | 2018 | 51 | 0.140 |
Why?
|
| Dystocia | 1 | 2017 | 23 | 0.140 |
Why?
|
| Uterine Rupture | 1 | 2017 | 18 | 0.140 |
Why?
|
| Pancreas | 5 | 2019 | 210 | 0.140 |
Why?
|
| Digestion | 2 | 2009 | 37 | 0.140 |
Why?
|
| Tissue Distribution | 4 | 2021 | 374 | 0.140 |
Why?
|
| Registries | 6 | 2018 | 1382 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 996 | 0.140 |
Why?
|
| Labor, Induced | 1 | 2017 | 36 | 0.140 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2013 | 68 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2018 | 384 | 0.140 |
Why?
|
| Weight Gain | 6 | 2019 | 401 | 0.140 |
Why?
|
| Energy Intake | 1 | 2019 | 487 | 0.130 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 2 | 2014 | 11 | 0.130 |
Why?
|
| Milk Substitutes | 2 | 2013 | 7 | 0.130 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2016 | 10 | 0.130 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2016 | 7 | 0.130 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2019 | 237 | 0.130 |
Why?
|
| Developing Countries | 1 | 1998 | 270 | 0.130 |
Why?
|
| Pregnancy, Multiple | 1 | 2016 | 50 | 0.130 |
Why?
|
| Epidemiological Monitoring | 1 | 2016 | 59 | 0.130 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 455 | 0.130 |
Why?
|
| Rats | 14 | 2017 | 3629 | 0.130 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2016 | 54 | 0.130 |
Why?
|
| Case-Control Studies | 5 | 2022 | 3259 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 420 | 0.130 |
Why?
|
| Urea | 3 | 2012 | 210 | 0.130 |
Why?
|
| Head | 1 | 2016 | 102 | 0.130 |
Why?
|
| Steroids | 1 | 2016 | 203 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2022 | 1524 | 0.130 |
Why?
|
| Hydrocephalus | 1 | 2018 | 237 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 29 | 0.120 |
Why?
|
| Intensive Care, Neonatal | 1 | 2015 | 54 | 0.120 |
Why?
|
| Education, Medical | 1 | 2019 | 285 | 0.120 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2022 | 50 | 0.120 |
Why?
|
| Dietary Fats | 1 | 2017 | 296 | 0.120 |
Why?
|
| Perinatal Mortality | 1 | 2015 | 42 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 392 | 0.120 |
Why?
|
| Cell Division | 6 | 2009 | 779 | 0.120 |
Why?
|
| Mucin-2 | 2 | 2012 | 35 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 868 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2017 | 379 | 0.120 |
Why?
|
| Brain Injuries | 1 | 2020 | 734 | 0.120 |
Why?
|
| Abdomen | 1 | 2015 | 130 | 0.120 |
Why?
|
| Respiration Disorders | 1 | 2014 | 30 | 0.120 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 291 | 0.120 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 254 | 0.120 |
Why?
|
| Demography | 3 | 2020 | 239 | 0.120 |
Why?
|
| Magnesium Sulfate | 1 | 2014 | 51 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 2 | 2004 | 141 | 0.110 |
Why?
|
| Hypotension | 1 | 2015 | 175 | 0.110 |
Why?
|
| Glutamates | 2 | 1991 | 68 | 0.110 |
Why?
|
| Energy Metabolism | 2 | 2001 | 766 | 0.110 |
Why?
|
| Nutritional Requirements | 3 | 2006 | 176 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2018 | 312 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1224 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 3 | 2016 | 163 | 0.110 |
Why?
|
| Blood Pressure | 3 | 2015 | 1314 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2019 | 696 | 0.110 |
Why?
|
| Social Conditions | 1 | 2013 | 6 | 0.110 |
Why?
|
| Sodium-Glucose Transporter 1 | 2 | 2010 | 11 | 0.110 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2014 | 57 | 0.110 |
Why?
|
| Organizational Innovation | 1 | 2013 | 44 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 69 | 0.110 |
Why?
|
| Tritium | 4 | 2009 | 173 | 0.110 |
Why?
|
| Infusions, Parenteral | 3 | 2021 | 99 | 0.110 |
Why?
|
| Child | 6 | 2024 | 24144 | 0.110 |
Why?
|
| Radioactive Tracers | 1 | 2012 | 20 | 0.110 |
Why?
|
| Length of Stay | 1 | 2018 | 1283 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2013 | 64 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 428 | 0.100 |
Why?
|
| Linear Models | 3 | 2022 | 671 | 0.100 |
Why?
|
| Aging | 1 | 2019 | 1173 | 0.100 |
Why?
|
| Thionucleosides | 1 | 2012 | 5 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2024 | 312 | 0.100 |
Why?
|
| Proline | 1 | 2012 | 72 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 51 | 0.100 |
Why?
|
| Survival Rate | 4 | 2021 | 1993 | 0.100 |
Why?
|
| Endpoint Determination | 1 | 2012 | 53 | 0.100 |
Why?
|
| Decision Making | 1 | 2017 | 650 | 0.100 |
Why?
|
| Apoptosis | 5 | 2006 | 1783 | 0.100 |
Why?
|
| Incretins | 1 | 2012 | 25 | 0.100 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2011 | 14 | 0.100 |
Why?
|
| Fetal Death | 2 | 2010 | 113 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2015 | 1470 | 0.100 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 143 | 0.100 |
Why?
|
| Nitrogen Isotopes | 3 | 2018 | 54 | 0.100 |
Why?
|
| Cells, Cultured | 7 | 2017 | 3050 | 0.100 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.100 |
Why?
|
| Metagenome | 1 | 2012 | 148 | 0.100 |
Why?
|
| Glutathione | 4 | 2011 | 193 | 0.090 |
Why?
|
| Growth Substances | 2 | 2002 | 113 | 0.090 |
Why?
|
| Adenosine | 1 | 2012 | 126 | 0.090 |
Why?
|
| Candida | 1 | 2011 | 75 | 0.090 |
Why?
|
| Malates | 1 | 1991 | 7 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 39 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 94 | 0.090 |
Why?
|
| Stomach | 3 | 2009 | 271 | 0.090 |
Why?
|
| Health Policy | 1 | 2013 | 211 | 0.090 |
Why?
|
| Rodentia | 2 | 2008 | 46 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 1991 | 73 | 0.090 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2010 | 35 | 0.090 |
Why?
|
| Animals, Domestic | 2 | 2017 | 30 | 0.090 |
Why?
|
| Fasting | 2 | 2005 | 296 | 0.090 |
Why?
|
| Infusions, Intravenous | 4 | 2018 | 533 | 0.090 |
Why?
|
| Dicarboxylic Acids | 1 | 1991 | 34 | 0.090 |
Why?
|
| Candidiasis | 1 | 2011 | 129 | 0.090 |
Why?
|
| Perfusion | 7 | 1994 | 197 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 370 | 0.090 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 1989 | 10 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2014 | 796 | 0.090 |
Why?
|
| Critical Illness | 1 | 2015 | 595 | 0.090 |
Why?
|
| RNA, Messenger | 6 | 2016 | 2820 | 0.090 |
Why?
|
| Pregnancy Outcome | 3 | 2018 | 595 | 0.090 |
Why?
|
| Feeding Methods | 2 | 2019 | 37 | 0.090 |
Why?
|
| Serum Amyloid A Protein | 3 | 2015 | 29 | 0.090 |
Why?
|
| Gene Expression | 5 | 2014 | 1569 | 0.080 |
Why?
|
| Poverty | 1 | 2013 | 419 | 0.080 |
Why?
|
| Treponema pallidum | 2 | 2019 | 49 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1642 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2014 | 483 | 0.080 |
Why?
|
| Bacterial Translocation | 2 | 2006 | 24 | 0.080 |
Why?
|
| Time Factors | 7 | 2020 | 6198 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2306 | 0.080 |
Why?
|
| Age of Onset | 2 | 2021 | 581 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2013 | 1166 | 0.080 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2021 | 35 | 0.080 |
Why?
|
| Rats, Inbred Strains | 5 | 1991 | 224 | 0.080 |
Why?
|
| Spleen | 2 | 2006 | 272 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 670 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2022 | 815 | 0.080 |
Why?
|
| Delivery Rooms | 2 | 2018 | 17 | 0.080 |
Why?
|
| Galactose | 2 | 2009 | 54 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 791 | 0.080 |
Why?
|
| Cerebral Palsy | 2 | 2022 | 79 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2595 | 0.080 |
Why?
|
| Pulmonary Surfactants | 2 | 2018 | 43 | 0.070 |
Why?
|
| Oxygen | 1 | 2011 | 540 | 0.070 |
Why?
|
| Syphilis Serodiagnosis | 2 | 1999 | 14 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2021 | 12087 | 0.070 |
Why?
|
| Deuterium | 2 | 2017 | 106 | 0.070 |
Why?
|
| Chorioamnionitis | 2 | 2018 | 41 | 0.070 |
Why?
|
| S-Adenosylmethionine | 1 | 2007 | 30 | 0.070 |
Why?
|
| Olive Oil | 2 | 2019 | 22 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2533 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2021 | 753 | 0.070 |
Why?
|
| Adenosine Triphosphate | 3 | 2006 | 286 | 0.070 |
Why?
|
| Biological Transport | 4 | 1991 | 347 | 0.070 |
Why?
|
| Microvilli | 4 | 2013 | 72 | 0.060 |
Why?
|
| Hexoses | 1 | 2005 | 11 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3005 | 0.060 |
Why?
|
| Trypsin | 1 | 2005 | 95 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 1684 | 0.060 |
Why?
|
| Rats, Wistar | 7 | 1996 | 359 | 0.060 |
Why?
|
| alpha-Glucosidases | 3 | 2013 | 26 | 0.060 |
Why?
|
| Carbon Radioisotopes | 2 | 1998 | 71 | 0.060 |
Why?
|
| Malabsorption Syndromes | 1 | 2005 | 37 | 0.060 |
Why?
|
| Peroxidase | 3 | 2012 | 61 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2004 | 671 | 0.060 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1997 | 43 | 0.060 |
Why?
|
| Models, Biological | 4 | 2009 | 1442 | 0.060 |
Why?
|
| Adolescent | 5 | 2020 | 19029 | 0.060 |
Why?
|
| Spontaneous Perforation | 1 | 2024 | 4 | 0.060 |
Why?
|
| Osmolar Concentration | 5 | 2001 | 172 | 0.060 |
Why?
|
| Cattle | 3 | 2013 | 559 | 0.060 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2004 | 6 | 0.060 |
Why?
|
| DNA | 4 | 2005 | 1592 | 0.060 |
Why?
|
| Enteroendocrine Cells | 2 | 2019 | 18 | 0.060 |
Why?
|
| Peroxides | 2 | 1994 | 13 | 0.060 |
Why?
|
| Plant Oils | 2 | 2014 | 32 | 0.060 |
Why?
|
| Zeaxanthins | 1 | 2023 | 9 | 0.060 |
Why?
|
| Lutein | 1 | 2023 | 15 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2004 | 423 | 0.060 |
Why?
|
| Pediatrics | 1 | 2013 | 1139 | 0.060 |
Why?
|
| Symporters | 1 | 2004 | 66 | 0.060 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2023 | 5 | 0.060 |
Why?
|
| Hepatic Artery | 1 | 2003 | 51 | 0.050 |
Why?
|
| Hormones | 2 | 2002 | 190 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 60 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2003 | 96 | 0.050 |
Why?
|
| Labor, Obstetric | 1 | 2003 | 96 | 0.050 |
Why?
|
| Carotenoids | 1 | 2023 | 75 | 0.050 |
Why?
|
| Nervous System | 1 | 2003 | 128 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 1845 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 5 | 0.050 |
Why?
|
| Gonorrhea | 1 | 1982 | 36 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2024 | 207 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 1294 | 0.050 |
Why?
|
| Ampicillin | 1 | 2022 | 58 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5031 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2013 | 867 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2004 | 326 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2011 | 1011 | 0.050 |
Why?
|
| Oxygen Consumption | 3 | 2011 | 303 | 0.050 |
Why?
|
| Dextran Sulfate | 2 | 2012 | 46 | 0.050 |
Why?
|
| Dogs | 2 | 2003 | 763 | 0.050 |
Why?
|
| Growth and Development | 1 | 2021 | 22 | 0.050 |
Why?
|
| Lactase-Phlorizin Hydrolase | 1 | 2001 | 21 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2016 | 1610 | 0.050 |
Why?
|
| Nucleotides | 1 | 2002 | 92 | 0.050 |
Why?
|
| Gentamicins | 1 | 2022 | 95 | 0.050 |
Why?
|
| Sex Factors | 2 | 2018 | 1254 | 0.050 |
Why?
|
| Gastrointestinal Hormones | 1 | 2001 | 21 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 100 | 0.050 |
Why?
|
| Charcoal | 1 | 1980 | 6 | 0.050 |
Why?
|
| G(M1) Ganglioside | 1 | 1980 | 8 | 0.050 |
Why?
|
| Sociological Factors | 1 | 2020 | 8 | 0.050 |
Why?
|
| Vagina | 1 | 2022 | 202 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2014 | 1102 | 0.050 |
Why?
|
| Cholera | 1 | 1980 | 25 | 0.050 |
Why?
|
| Cholera Toxin | 1 | 1980 | 45 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2022 | 281 | 0.050 |
Why?
|
| Blood Culture | 1 | 2021 | 29 | 0.050 |
Why?
|
| Soybean Proteins | 1 | 2000 | 18 | 0.040 |
Why?
|
| Age Factors | 3 | 2017 | 2801 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 4342 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2002 | 369 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2020 | 93 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2001 | 97 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2007 | 991 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 49 | 0.040 |
Why?
|
| Gangliosides | 1 | 1980 | 64 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2024 | 1585 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 3325 | 0.040 |
Why?
|
| Body Composition | 2 | 2019 | 513 | 0.040 |
Why?
|
| Regional Blood Flow | 3 | 2006 | 210 | 0.040 |
Why?
|
| Child Health | 1 | 2020 | 53 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 41 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2001 | 340 | 0.040 |
Why?
|
| Bottle Feeding | 1 | 2019 | 36 | 0.040 |
Why?
|
| Lactates | 1 | 1999 | 89 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2001 | 354 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2000 | 116 | 0.040 |
Why?
|
| Algorithms | 3 | 2017 | 1596 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 59 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 69 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 228 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2021 | 674 | 0.040 |
Why?
|
| Sucrase | 2 | 2013 | 22 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 1996 | 10 | 0.040 |
Why?
|
| Mathematics | 1 | 1998 | 99 | 0.040 |
Why?
|
| Dipeptides | 1 | 2018 | 56 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2023 | 1166 | 0.040 |
Why?
|
| Glycine | 3 | 1997 | 160 | 0.040 |
Why?
|
| Albumins | 1 | 1998 | 88 | 0.040 |
Why?
|
| Atrophy | 2 | 2011 | 225 | 0.040 |
Why?
|
| Fibrinogen | 1 | 1998 | 151 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2019 | 219 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 217 | 0.040 |
Why?
|
| Arteries | 1 | 1999 | 222 | 0.040 |
Why?
|
| Methylation | 2 | 2009 | 227 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 218 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 458 | 0.040 |
Why?
|
| Maternal Age | 1 | 2018 | 136 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2018 | 134 | 0.040 |
Why?
|
| Pentoxifylline | 1 | 2017 | 20 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 49 | 0.040 |
Why?
|
| Granulocytes | 1 | 2017 | 65 | 0.040 |
Why?
|
| Micelles | 1 | 2017 | 19 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 2017 | 53 | 0.040 |
Why?
|
| Carbon | 1 | 1997 | 87 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 67 | 0.030 |
Why?
|
| Weaning | 2 | 2011 | 41 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 155 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 85 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 372 | 0.030 |
Why?
|
| Raffinose | 2 | 1994 | 6 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2017 | 116 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2016 | 35 | 0.030 |
Why?
|
| Asia, Western | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mice | 4 | 2017 | 17469 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2017 | 158 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 34 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 141 | 0.030 |
Why?
|
| Back Muscles | 1 | 2016 | 4 | 0.030 |
Why?
|
| Blindness | 1 | 2016 | 71 | 0.030 |
Why?
|
| Amino Acid Transport System A | 1 | 2016 | 7 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 449 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 185 | 0.030 |
Why?
|
| Deafness | 1 | 2016 | 81 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 78 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 549 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2016 | 28 | 0.030 |
Why?
|
| Perinatal Care | 1 | 2016 | 67 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 37 | 0.030 |
Why?
|
| Sympathomimetics | 1 | 2015 | 11 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 187 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2011 | 310 | 0.030 |
Why?
|
| Ion Channels | 1 | 2017 | 188 | 0.030 |
Why?
|
| Patient Participation | 1 | 2018 | 220 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2018 | 220 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2015 | 35 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 374 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2016 | 73 | 0.030 |
Why?
|
| Cell Size | 2 | 1992 | 81 | 0.030 |
Why?
|
| Dobutamine | 1 | 2015 | 56 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 1996 | 76 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2019 | 440 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2006 | 64 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 447 | 0.030 |
Why?
|
| Echoencephalography | 1 | 2015 | 25 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 277 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 172 | 0.030 |
Why?
|
| Caspases | 2 | 2006 | 159 | 0.030 |
Why?
|
| Health Behavior | 1 | 2018 | 382 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 174 | 0.030 |
Why?
|
| Neurosyphilis | 1 | 1994 | 14 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 207 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 256 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 370 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 771 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 137 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Sorbitol | 1 | 2014 | 6 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1994 | 113 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 40 | 0.030 |
Why?
|
| Dopamine | 1 | 2015 | 275 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4221 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 298 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1211 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 522 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 424 | 0.030 |
Why?
|
| Cross Infection | 1 | 2017 | 332 | 0.030 |
Why?
|
| Cell Count | 2 | 2004 | 248 | 0.030 |
Why?
|
| Animals, Inbred Strains | 1 | 2013 | 5 | 0.030 |
Why?
|
| Enzyme Precursors | 2 | 2004 | 22 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 2 | 2004 | 185 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1386 | 0.030 |
Why?
|
| Caprylates | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cell Survival | 2 | 2006 | 803 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 258 | 0.030 |
Why?
|
| Bucladesine | 1 | 1992 | 19 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 271 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 143 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 491 | 0.030 |
Why?
|
| Phenylephrine | 1 | 1992 | 36 | 0.030 |
Why?
|
| Vasopressins | 1 | 1992 | 43 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 142 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2014 | 167 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 1992 | 44 | 0.030 |
Why?
|
| Immunoassay | 1 | 1993 | 127 | 0.030 |
Why?
|
| Mucins | 1 | 2012 | 74 | 0.030 |
Why?
|
| Keto Acids | 1 | 1992 | 55 | 0.030 |
Why?
|
| Ketones | 1 | 1992 | 24 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2016 | 555 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 2227 | 0.030 |
Why?
|
| Bifidobacterium | 1 | 2012 | 63 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2013 | 208 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 2837 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 171 | 0.020 |
Why?
|
| Anesthesia | 1 | 2014 | 209 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 13 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 15 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 14 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 231 | 0.020 |
Why?
|
| Mesentery | 1 | 2011 | 28 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 343 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 252 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 71 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1089 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2013 | 303 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 2001 | 143 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 25931 | 0.020 |
Why?
|
| Hepatic Veins | 1 | 1991 | 22 | 0.020 |
Why?
|
| Peptide YY | 2 | 2001 | 18 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2546 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2010 | 58 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 513 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 230 | 0.020 |
Why?
|
| Actins | 1 | 1992 | 341 | 0.020 |
Why?
|
| Catheterization | 2 | 2002 | 234 | 0.020 |
Why?
|
| Isotopes | 1 | 2009 | 27 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 170 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 2009 | 19 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2010 | 93 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 696 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1390 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 155 | 0.020 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
|
| Uracil Nucleotides | 1 | 1988 | 17 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 1988 | 11 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 1988 | 20 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 75 | 0.020 |
Why?
|
| Ammonia | 1 | 1989 | 68 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1586 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2009 | 143 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1005 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 475 | 0.020 |
Why?
|
| Ischemia | 1 | 2011 | 337 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2009 | 99 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 398 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 313 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 4 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2041 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 51 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 37 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 53 | 0.020 |
Why?
|
| fas Receptor | 1 | 2006 | 41 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 70 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 89 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 76 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 159 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 94 | 0.020 |
Why?
|
| Ribotyping | 1 | 2006 | 45 | 0.020 |
Why?
|
| Enterotoxins | 1 | 2006 | 82 | 0.020 |
Why?
|
| Blood | 1 | 2006 | 105 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 151 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 111 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2006 | 18 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 426 | 0.020 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2005 | 8 | 0.020 |
Why?
|
| Bilirubin | 1 | 2006 | 120 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 661 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 141 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 56 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 210 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2006 | 176 | 0.020 |
Why?
|
| Caspase 6 | 1 | 2004 | 4 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2004 | 29 | 0.020 |
Why?
|
| Texas | 1 | 2013 | 3542 | 0.010 |
Why?
|
| Sodium Chloride | 2 | 1994 | 97 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 131 | 0.010 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2004 | 4 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2004 | 29 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 757 | 0.010 |
Why?
|
| tert-Butylhydroperoxide | 2 | 1994 | 9 | 0.010 |
Why?
|
| Infant Food | 1 | 2004 | 81 | 0.010 |
Why?
|
| Claudin-1 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Enterocytes | 1 | 2004 | 66 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 2003 | 4 | 0.010 |
Why?
|
| Animals, Suckling | 1 | 2003 | 50 | 0.010 |
Why?
|
| Tight Junctions | 1 | 2003 | 37 | 0.010 |
Why?
|
| Liver Circulation | 1 | 2003 | 24 | 0.010 |
Why?
|
| Diuresis | 1 | 2003 | 58 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3510 | 0.010 |
Why?
|
| Permeability | 1 | 2003 | 118 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2003 | 62 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 52 | 0.010 |
Why?
|
| Enteritis | 1 | 2003 | 54 | 0.010 |
Why?
|
| Hypotonic Solutions | 2 | 1992 | 15 | 0.010 |
Why?
|
| Colon | 1 | 2005 | 353 | 0.010 |
Why?
|
| Jugular Veins | 1 | 2002 | 72 | 0.010 |
Why?
|
| Parity | 1 | 1982 | 79 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 636 | 0.010 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2003 | 66 | 0.010 |
Why?
|
| Glucagon | 2 | 1992 | 185 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 140 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 459 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2002 | 151 | 0.010 |
Why?
|
| Obstetric Labor Complications | 1 | 1982 | 96 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1996 | 966 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1994 | 247 | 0.010 |
Why?
|
| Scintillation Counting | 1 | 2001 | 6 | 0.010 |
Why?
|
| Georgia | 1 | 2001 | 29 | 0.010 |
Why?
|
| CD13 Antigens | 1 | 2001 | 15 | 0.010 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2001 | 19 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 549 | 0.010 |
Why?
|
| Adsorption | 1 | 1980 | 32 | 0.010 |
Why?
|
| Intestine, Large | 1 | 2000 | 15 | 0.010 |
Why?
|
| Urban Health | 1 | 2001 | 73 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 98 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2001 | 96 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 123 | 0.010 |
Why?
|
| Dehydration | 1 | 1980 | 37 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 2001 | 97 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2001 | 98 | 0.010 |
Why?
|
| Gastrins | 1 | 2000 | 32 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 2001 | 83 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2000 | 46 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 208 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 1542 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1999 | 247 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2698 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2001 | 383 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 576 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 327 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 945 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3871 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 382 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 1997 | 44 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1997 | 52 | 0.010 |
Why?
|
| Cell Movement | 1 | 2001 | 831 | 0.010 |
Why?
|
| Feces | 1 | 1980 | 710 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1997 | 107 | 0.010 |
Why?
|
| Tyrosine Transaminase | 1 | 1996 | 12 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 262 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1980 | 1088 | 0.010 |
Why?
|
| Anisotropy | 1 | 1996 | 122 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 258 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 1926 | 0.010 |
Why?
|
| Maleimides | 1 | 1994 | 12 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1994 | 23 | 0.010 |
Why?
|
| Lumicolchicines | 1 | 1994 | 1 | 0.010 |
Why?
|
| Barium Compounds | 1 | 1994 | 6 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1994 | 7 | 0.010 |
Why?
|
| Mass Screening | 1 | 2001 | 786 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1994 | 10 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1994 | 35 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1994 | 30 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1994 | 60 | 0.010 |
Why?
|
| Colchicine | 1 | 1994 | 43 | 0.010 |
Why?
|
| Dextrans | 1 | 1994 | 46 | 0.010 |
Why?
|
| Histidine | 1 | 1994 | 72 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1994 | 87 | 0.010 |
Why?
|
| Chlorides | 1 | 1994 | 104 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2021 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 2393 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1994 | 150 | 0.010 |
Why?
|
| Endocytosis | 1 | 1994 | 124 | 0.010 |
Why?
|
| Indoles | 1 | 1994 | 181 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 260 | 0.010 |
Why?
|
| Dinitrochlorobenzene | 1 | 1992 | 2 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1992 | 20 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 1063 | 0.010 |
Why?
|
| Osmosis | 1 | 1992 | 14 | 0.010 |
Why?
|
| Bile | 1 | 1992 | 46 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1992 | 31 | 0.010 |
Why?
|
| NAD | 1 | 1992 | 48 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 1994 | 481 | 0.010 |
Why?
|
| Phosphorylases | 1 | 1988 | 15 | 0.010 |
Why?
|
| Acetophenones | 1 | 1988 | 13 | 0.010 |
Why?
|
| Dinoprost | 1 | 1988 | 28 | 0.010 |
Why?
|
| Tetrazoles | 1 | 1988 | 63 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1988 | 619 | 0.000 |
Why?
|